Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E, Tang J, Sang BC, Verner E, Wynands R, Leahy EM, Dougan DR, Snell G, Navre M, Knuth MW, Swanson RV, McRee DE, Tari LW.

Structure. 2004 Jul;12(7):1325-34.

2.

Novel structural insights into class I and II histone deacetylases.

Ficner R.

Curr Top Med Chem. 2009;9(3):235-40. Review.

PMID:
19355988
3.

Histone deacetylases--an important class of cellular regulators with a variety of functions.

Hildmann C, Riester D, Schwienhorst A.

Appl Microbiol Biotechnol. 2007 Jun;75(3):487-97. Review.

PMID:
17377789
4.
5.

Class II histone deacetylases: structure, function, and regulation.

Bertos NR, Wang AH, Yang XJ.

Biochem Cell Biol. 2001;79(3):243-52. Review.

PMID:
11467738
6.

Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.

Hodawadekar SC, Marmorstein R.

Oncogene. 2007 Aug 13;26(37):5528-40. Review.

PMID:
17694092
7.

Histone deacetylases (HDACs): characterization of the classical HDAC family.

de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB.

Biochem J. 2003 Mar 15;370(Pt 3):737-49. Review.

8.

Class IIa histone deacetylases: regulating the regulators.

Martin M, Kettmann R, Dequiedt F.

Oncogene. 2007 Aug 13;26(37):5450-67. Review.

PMID:
17694086
9.

Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.

Codd R, Braich N, Liu J, Soe CZ, Pakchung AA.

Int J Biochem Cell Biol. 2009 Apr;41(4):736-9. doi: 10.1016/j.biocel.2008.05.026. Review.

PMID:
18725319
10.

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.

Gallinari P, Di Marco S, Jones P, Pallaoro M, Steink├╝hler C.

Cell Res. 2007 Mar;17(3):195-211. Review.

11.

Structural biology of human metal-dependent histone deacetylases.

Schapira M.

Handb Exp Pharmacol. 2011;206:225-40. doi: 10.1007/978-3-642-21631-2_10. Review.

PMID:
21879452
12.

The structure and function of histone deacetylases: the target for anti-cancer therapy.

Zhang Y, Fang H, Jiao J, Xu W.

Curr Med Chem. 2008;15(27):2840-9. Review.

PMID:
18991639
13.

Histone deacetylase: a target for antiproliferative and antiprotozoal agents.

Meinke PT, Liberator P.

Curr Med Chem. 2001 Feb;8(2):211-35. Review.

PMID:
11172676
14.

HDAC8 substrates: Histones and beyond.

Wolfson NA, Pitcairn CA, Fierke CA.

Biopolymers. 2013 Feb;99(2):112-26. doi: 10.1002/bip.22135. Review.

15.

The role of histone deacetylases (HDACs) in human cancer.

Ropero S, Esteller M.

Mol Oncol. 2007 Jun;1(1):19-25. doi: 10.1016/j.molonc.2007.01.001. Review.

16.

Histone deacetylases as transducers and targets of nuclear signaling.

Walkinshaw DR, Tahmasebi S, Bertos NR, Yang XJ.

J Cell Biochem. 2008 Aug 1;104(5):1541-52. doi: 10.1002/jcb.21746. Review.

PMID:
18425769
17.

Histone deacetylation as a target for radiosensitization.

Cerna D, Camphausen K, Tofilon PJ.

Curr Top Dev Biol. 2006;73:173-204. Review.

PMID:
16782459
18.
19.

NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

Vaquero A, Sternglanz R, Reinberg D.

Oncogene. 2007 Aug 13;26(37):5505-20. Review.

PMID:
17694090
20.

Regulation of histone deacetylase activities.

Sengupta N, Seto E.

J Cell Biochem. 2004 Sep 1;93(1):57-67. Review.

PMID:
15352162

Supplemental Content

Support Center